CorMedix Market Cap

CorMedix has a market cap or net worth of $420.12 million as of November 2, 2026. It is the 15,573rd most valuable company in the world and the 2,855th biggest in the United States. Its market cap has decreased by 49.43% in one year.

Market Cap

420.12M

Enterprise Value

310.88M

1-Year Change

-49.43%

Global Rank

#15,573

Country Rank

#2,855 United States

ChartMarket Cap Chart

Chart

Since May 13, 2010, CorMedix's market cap has increased from $34.20M to $420.12M, an increase of 1,128.42%. That is a compound annual growth rate of 16.43%.

Market Cap History

Date	Market Cap	% Change
Nov 2, 2026	420.12M	-54.15%
Dec 31, 2025	916.30M	86.43%
Dec 31, 2024	491.50M	138.48%
Dec 29, 2023	206.10M	18.31%
Dec 30, 2022	174.20M	0.52%
Dec 31, 2021	173.30M	-27.40%
Dec 31, 2020	238.70M	27.78%
Dec 31, 2019	186.80M	37.45%
Dec 31, 2018	135.90M	304.46%
Dec 29, 2017	33.60M	-45.72%
Dec 30, 2016	61.90M	-13.79%
Dec 31, 2015	71.80M	67.76%
Dec 31, 2014	42.80M	114.00%
Dec 31, 2013	20.00M	143.90%
Dec 31, 2012	8.20M	156.25%
Dec 30, 2011	3.20M	-84.62%
Dec 31, 2010	20.80M	-39.18%
May 13, 2010	34.20M	-

View and export this data all the way back to 2010. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
REGENXBIO	475.29M
Indaptus Therapeutics	474.57M
Monopar Therapeutics	472.00M
Phathom Pharmaceuticals	455.93M
Eupraxia Pharmaceuticals	449.68M
BlossomHill Therapeutics	437.04M
Prothena Corporation	434.82M
MapLight Therapeutics	421.26M

Market Cap Rankings